Breaking News Instant updates and real-time market news.

ANAB

AnaptysBio

$78.32

3.15 (4.19%)

06:59
08/07/18
08/07
06:59
08/07/18
06:59

AnaptysBio to deprioritize development of etokimab in peanut allergy

AnaptysBio said in today's earnings release, "As a result of market assessment regarding the adoption of the peanut oral food challenge in future commercial usage of etokimab in peanut allergy patients, AnaptysBio has decided to deprioritize further company-sponsored clinical development of etokimab in moderate-to-severe baseline adult peanut allergy patients. At this time, AnaptysBio does not intend to utilize its clinical development resources to pursue a Phase 2b clinical trial of etokimab in peanut allergy, however the Company may pursue potential investigator-sponsored trials related to this indication."

  • 14

    Aug

ANAB AnaptysBio
$78.32

3.15 (4.19%)

04/04/18
RBCM
04/04/18
DOWNGRADE
Target $86
RBCM
Sector Perform
AnaptysBio downgraded to Sector Perform at RBC Capital on ANB020 uncertainty
As reported earlier, RBC Capital analyst Kennen MacKay downgraded AnaptysBio to Sector Perform from Outperform and lowered his price target to $86 from $144. MacKay cites "increasing skepticism regarding ANB020's path forward in peanut allergy" as post-data credibility concerns create an unfavorable risk-reward going into the company's phase 2a asthma readout expected in Q3. While the analyst expects the ANB020 readout to show a benefit vs. placebo, the results may be "challenging to interpret" relative to the treatment's competition.
05/29/18
JMPS
05/29/18
NO CHANGE
JMPS
JMP says AnaptysBio weakness ahead of asthma read-out a buying opportunity
After Aimmune Therapeutics (AIMT) presented new results from its Phase 3 trial of AR101 in peanut allergy at a medical congress, JMP Securities analyst Konstantinos Aprilakis noted that shares of competitor AnaptysBio (ANAB) are off about 42% over the last three months. He remains a buyer of AnaptysBio on any weakness going into the top-line proof of concept data from the Phase 2a trial of ANB020 in eosinophilic asthma, which is expected in Q3. The analyst, who reminds investors that he assigns about $61/share for the eosinophilic asthma indication in his valuation of AnaptysBio, maintains an Outperform rating and $180 price target on AnaptysBio shares, which closed Friday at $77.90.
07/09/18
JEFF
07/09/18
NO CHANGE
Target $145
JEFF
Buy
AnaptysBio can rally up to $30 on upcoming asthma data, says Jefferies
Jefferies analyst Biren Amin previews this quarter's readout of AnaptysBio's Phase IIa study testing ANB020 in severe asthma. The analyst's analysis suggests most biologics deliver 6%-9% improvement in lung function. A 7%-8% improvement likely drives $15-$20 of share upside while 9%-10% likely pushes the stock up $25-$30, Amin tells investors in a research note. He believes a the lower range of a 5%-6% improvement could trigger a selloff of $10-$15 per share and a true miss of less than 5% improvement could see the stock down $20-$25. He keeps a Buy rating on AnaptysBio with a $145 price target.
07/19/18
FBCO
07/19/18
INITIATION
Target $104
FBCO
Outperform
AnaptysBio initiated with an Outperform at Credit Suisse
Credit Suisse initiated AnaptysBio with an Outperform and $104 price target.

TODAY'S FREE FLY STORIES

RF

Regions Financial

$14.60

-0.27 (-1.82%)

14:45
06/19/19
06/19
14:45
06/19/19
14:45
Options
Regions Financial call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

14:45
06/19/19
06/19
14:45
06/19/19
14:45
General news
Fed Chair Powell opened his presser noting "significant changes" »

Fed Chair Powell opened…

SPY

SPDR S&P 500 ETF Trust

$292.63

0.3 (0.10%)

, SPX

S&P 500

$0.00

(0.00%)

14:44
06/19/19
06/19
14:44
06/19/19
14:44
General news
Powell: Trade 'important driver of sentiment,' but Fed not focused on one thing »

Asked if a trade deal…

SPY

SPDR S&P 500 ETF Trust

$292.63

0.3 (0.10%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$292.64

0.31 (0.11%)

, SPX

S&P 500

$0.00

(0.00%)

14:43
06/19/19
06/19
14:43
06/19/19
14:43
General news
Powell says 'law is clear I have a 4-year term,' 'fully intend to serve it' »

Asked how he would react…

SPY

SPDR S&P 500 ETF Trust

$292.64

0.31 (0.11%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:42
06/19/19
06/19
14:42
06/19/19
14:42
Conference/Events
Stephens retail/broadlines analyst to hold a luncheon meeting »

Retail/Broadlines Analyst…

DIS

Disney

$140.09

0.88 (0.63%)

14:41
06/19/19
06/19
14:41
06/19/19
14:41
Periodicals
More layoffs from Disney and 20th Century Fox film divisions, Variety reports »

Matt Donelly and Brent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

SPY

SPDR S&P 500 ETF Trust

$292.48

0.15 (0.05%)

, SPX

S&P 500

$0.00

(0.00%)

14:40
06/19/19
06/19
14:40
06/19/19
14:40
General news
Powell says will be monitoring 'cross-currents,' but would 'like to see more' »

"Many" on the…

SPY

SPDR S&P 500 ETF Trust

$292.48

0.15 (0.05%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:40
06/19/19
06/19
14:40
06/19/19
14:40
Conference/Events
Stephens telecom, media & tech analyst to hold a luncheon »

Analysts hold a…

AAPL

Apple

$198.16

-0.36 (-0.18%)

, GS

Goldman Sachs

$195.66

0.68 (0.35%)

14:38
06/19/19
06/19
14:38
06/19/19
14:38
Periodicals
Apple expanding Goldman Sachs card test, Bloomberg reports »

Apple (AAPL) has launched…

AAPL

Apple

$198.16

-0.36 (-0.18%)

GS

Goldman Sachs

$195.66

0.68 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 09

    Jul

  • 16

    Jul

RHHBY

Roche

$0.00

(0.00%)

14:38
06/19/19
06/19
14:38
06/19/19
14:38
Conference/Events
Wolfe Research pharma analyst to hold an analyst/industry conference call »

Global Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 27

    Jun

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 26

    Aug

  • 02

    Sep

  • 04

    Nov

SPY

SPDR S&P 500 ETF Trust

$292.77

0.44 (0.15%)

, SPX

S&P 500

$0.00

(0.00%)

14:37
06/19/19
06/19
14:37
06/19/19
14:37
General news
Powell says must rely on 'imperfect' inflation expectation proxies »

Fed Chair Powell said…

SPY

SPDR S&P 500 ETF Trust

$292.77

0.44 (0.15%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRUB

GrubHub

$71.04

-0.13 (-0.18%)

, YELP

Yelp

$32.80

-0.13 (-0.39%)

14:36
06/19/19
06/19
14:36
06/19/19
14:36
Conference/Events
Wedbush SMid Internet analyst to hold a luncheon meeting »

SMID Internet Analyst…

GRUB

GrubHub

$71.04

-0.13 (-0.18%)

YELP

Yelp

$32.80

-0.13 (-0.39%)

BWLD

Taken private 2/18

$0.00

(0.00%)

CAKE

Cheesecake Factory

$44.35

-1.2 (-2.63%)

BJRI

BJ's Restaurants

$41.00

-1.6 (-3.76%)

CMG

Chipotle

$731.31

-1.41 (-0.19%)

JACK

Jack in the Box

$84.75

-1.61 (-1.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 23

    Jul

  • 08

    Aug

14:35
06/19/19
06/19
14:35
06/19/19
14:35
General news
FOMC forecast Revisions »

FOMC forecast Revisions…

SPY

SPDR S&P 500 ETF Trust

$293.00

0.67 (0.23%)

, SPX

S&P 500

$0.00

(0.00%)

14:33
06/19/19
06/19
14:33
06/19/19
14:33
General news
Powell says Fed made 'significant' changes to policy statement »

Fed Chair Jerome Powell…

SPY

SPDR S&P 500 ETF Trust

$293.00

0.67 (0.23%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INGN

Inogen

$70.97

-0.13 (-0.18%)

14:32
06/19/19
06/19
14:32
06/19/19
14:32
Conference/Events
William Blair medical tech analyst to hold a luncheon »

Medical Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 26

    Aug

  • 26

    Aug

BJRI

BJ's Restaurants

$41.14

-1.46 (-3.43%)

, CAKE

Cheesecake Factory

$44.50

-1.05 (-2.31%)

14:29
06/19/19
06/19
14:29
06/19/19
14:29
Conference/Events
Wedbush restaurants analyst to hold an analyst/industry conference call »

Restaurants Analyst…

BJRI

BJ's Restaurants

$41.14

-1.46 (-3.43%)

CAKE

Cheesecake Factory

$44.50

-1.05 (-2.31%)

CMG

Chipotle

$729.53

-3.19 (-0.44%)

DIN

Dine Brands

$95.61

-0.39 (-0.41%)

DRI

Darden

$117.36

-0.58 (-0.49%)

JACK

Jack in the Box

$84.90

-1.46 (-1.69%)

SBUX

Starbucks

$83.34

0.39 (0.47%)

TXRH

Texas Roadhouse

$52.30

-1.07 (-2.00%)

WEN

Wendy's

$19.44

0.03 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 23

    Jul

  • 08

    Aug

  • 14

    Aug

  • 27

    Aug

  • 28

    Aug

  • 13

    Nov

14:27
06/19/19
06/19
14:27
06/19/19
14:27
Conference/Events
William Blair financial services/insurance analyst to hold a luncheon »

Financial…

CTSH

Cognizant

$63.45

-0.27 (-0.42%)

14:25
06/19/19
06/19
14:25
06/19/19
14:25
Options
Cognizant call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

14:25
06/19/19
06/19
14:25
06/19/19
14:25
General news
More from the FOMC: a couple of other tweaks the statement »

More from the FOMC: a…

14:24
06/19/19
06/19
14:24
06/19/19
14:24
Conference/Events
CLSA Asian tech analysts to hold an analyst/industry conference call »

Asian Technology Analysts…

UNH

UnitedHealth

$250.20

4.55 (1.85%)

, DVA

DaVita

$51.25

1.49 (2.99%)

14:23
06/19/19
06/19
14:23
06/19/19
14:23
Periodicals
Breaking Periodicals news story on UnitedHealth, DaVita »

FTC set to approve sale…

UNH

UnitedHealth

$250.20

4.55 (1.85%)

DVA

DaVita

$51.25

1.49 (2.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

TSLA

Tesla

$227.28

2.6 (1.16%)

14:22
06/19/19
06/19
14:22
06/19/19
14:22
Hot Stocks
Tesla CEO says $1,000 charge for black vehicles to start next month »

Elon Musk, CEO of Tesla,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,105.94

1.54 (0.14%)

, GOOGL

Alphabet Class A

$1,107.59

2.37 (0.21%)

14:21
06/19/19
06/19
14:21
06/19/19
14:21
Periodicals
FTC in late stages of YouTube probe over children content, Washington Post says »

The Federal Trade…

GOOG

Alphabet

$1,105.94

1.54 (0.14%)

GOOGL

Alphabet Class A

$1,107.59

2.37 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 19

    Jun

  • 09

    Jul

  • 10

    Jul

  • 27

    Oct

SYNL

Synalloy

$16.52

-0.27 (-1.61%)

14:21
06/19/19
06/19
14:21
06/19/19
14:21
Earnings
Synalloy lowers FY19 revenue view to $329M from prior $340M »

Adjusted EBITDA for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$55.26

0.6 (1.10%)

14:20
06/19/19
06/19
14:20
06/19/19
14:20
Conference/Events
CVS Health participates in a conference call with Morgan Stanley »

Healthcare Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.